ADIAL PHARMACEUTICALS, INC.

ADIAL PHARMACEUTICALS, INC. (ticker: ADIL) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of ADIL's SEC filings surfaces 5 active risk signals, including 2 auditor-change signals, 2 late-filing signals, and 1 delisting/deregistration signal. ADIL reported no tagged revenue in revenue and -$2.02M for the period ending 2026-03-31, with operating cash flow of -$1.61M. Cash and equivalents stood at $4.58M (up 93.8% year-over-year). Total assets of $5.23M exceed total liabilities of $1.51M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.